Top companies

ASIANPAINT - 2435.8 (-1.93%) AXISBANK - 1141.25 (0.64%) BAJAJFINSV - 1575.8 (-1.29%) BAJFINANCE - 6479.8 (-1.75%) BHARTIARTL - 1519.2 (-0.41%) BPCL - 282.6 (-1.7%) COALINDIA - 405.8 (-1.56%) HDFCBANK - 1744.35 (0.12%) HEROMOTOCO - 4752.5 (-0.49%) HINDUNILVR - 2380.4 (-1.24%) ICICIBANK - 1251.35 (0.18%) INDUSINDBK - 974.9 (-2.53%) ITC - 456.95 (-2.23%) KOTAKBANK - 1734.7 (0.4%) MARUTI - 10898.15 (-0.56%) ONGC - 242.25 (-2.32%) RELIANCE - 1223.7 (-1.45%) SBIN - 782.85 (-2.51%) TATAMOTORS - 778.15 (-0.64%) TATASTEEL - 140.94 (1.06%) TCS - 4032.55 (-0.17%) TITAN - 3162.05 (-1.94%) WIPRO - 556.35 (-1.01%)
TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

Brokerage Radar: HSBC trims Glenmark Pharma's target, Morgan Stanley upgrades Suzlon Energy

19 Nov , 2024   By : Debdeep Gupta


Brokerage Radar: HSBC trims Glenmark Pharma's target, Morgan Stanley upgrades Suzlon Energy

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Glenmark Pharma, financial stocks, and more.


Glenmark Pharma


HSBC On Glenmark Pharma

Hold Call, Target Cut To `1,600/Sh From `1,660/Sh

Q2 Below Estimates, Mainly On Higher Overheads; Strong India Sales In Otherwise Lacklustre Quarter

New Launches And Supplies From Monroe Plant Key For Pick-Up In US Sales

New Launches And Supplies From Monroe Plant Is Key For Better Margins

Look For Improved Execution In The US Segment


MOSL On Glenmark Pharma

Buy Call, Target At `1,820/Sh

India, Europe Drive Earnings

Work-in-progress To Resolve Monroe USFDA Issue

Improved Product Mix Offset By Higher Marketing/Freight Costs

Co Expects Approval For Ryaltris NDA In China In FY26

Plans To File Envafolimab In More Than 20 Markets In FY25 & The First Mkt Launch Is Expected In FY26

For Ichnos Glenmark Innovation (IGI), R&D Spending Will Be $60-70 m Per Year Going Forward


Jefferies On Indian Hotels

Buy Call, Target At `785/Sh

Co Is Up 68% CYTD & 3x Since May’22, When It Presented Its Margin & Brand Portfolio Goals By 2025

Goals Set By The Co Has Already Been Surpassed

On Numbers, Management Has Refrained From Giving Any New Guidance On Margins

Management Has Rather Focused On Guiding And Maintaining Overall Growth

Guiding And Maintaining Overall Growth May Be A Talking Point Today As Well

Look Forward To Hearing About New Strategic Initiatives Towards Meeting Goals Of Consistent Growth


Morgan Stanley On Suzlon Energy

Upgrade To Overweight, Target At `71/Sh

Steep Correction An Opportunity To Accumulate

Believe Suzlon’s Business Moat & Growth Opportunity For Wind OEMs Both Remain Strong Factors

FY25 Sales Volume Lowered To 1.3 GW Vs 1.5 GW Earlier

FY25-27 Total Sales Volume Unchanged At 7.15 GW


Jefferies On Financials

Retail NPL Cycle May Be A Shallower Cycle, Especially For Leading Banks

Moderation In Unsecured Loan Growth May Be Partly Made Up By SME Loans

Banks Aren't As Aligned On Rates/ Liquidity & Sector Loan Growth

Life Insurers Seem Confident To Manage Impact Of Surrender Charges & Cap

Market Players Are in a Sweet Spot

Channel Checks Offered Constructive Feedback On Affordable HFCs

0 Comment


LEAVE A COMMENT


Growmudra © 2024 all right reserved

Partner With Us